Cardiol Share Price
NASDAQ: CRDL | OthersCardiol Stock Performance
Cardiol Share Price Today
As of 19 November 2026, Cardiol Therapeutics Inc. Class A's share price is $0.94. The stock opened at $0.97, compared to its previous close of $0.96. During today's trading session, Cardiol Therapeutics Inc. Class A's share price traded between $0.95 and $0.97, with an average price of $0.96. Over the past 52 weeks, the stock has recorded a high of $2.34 and a low of $0.88. In terms of performance, Cardiol Therapeutics Inc. Class A's share price has declined by 22.84% over the last six months and is down 9.91% on a year-on-year basis.
Cardiol Share Price Chart
About Cardiol
Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.
Cardiol Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.11 | $0.95 | -16.28% |
Oct 2026 | $1.64 | $1.13 | -32.13% |
Sep 2026 | $1.95 | $1.67 | -19.17% |
Aug 2026 | $1.23 | $2.06 | +63.49% |
Jul 2026 | $1.06 | $1.26 | +20.00% |
Jun 2026 | $1.24 | $1.05 | -13.93% |
May 2026 | $1.36 | $1.22 | -11.59% |
Apr 2026 | $1.39 | $1.38 | +1.85% |
Mar 2026 | $1.01 | $1.35 | +32.84% |
Feb 2026 | $0.94 | $1.02 | +7.37% |
Jan 2026 | $0.98 | $0.95 | -0.73% |
Dec 2025 | $1.10 | $0.96 | -8.42% |